Author

Migdalia E. Gonzalez

Observed name: Migdalia Gonzalez

ORCID: 0009-0008-3789-3849

Observed ORCID: 0009-0008-3789-3849

OpenAlex ID: A5113400265

PLK1 Inhibitor Onvansertib Enhances the Efficacy of Alpelisib in PIK3CA-Mutated HR-Positive Breast Cancer Resistant to Palbociclib and Endocrine Therapy: Preclinical Insights

2024 · Sreeja Sreekumar, Elodie Montaudon, et al. · Cancers · 6

PLK1 Inhibition by Onvansertib Enhances Paclitaxel Efficacy and Overcomes Resistance in HR+/HER2− Breast Cancer Refractory to Endocrine Therapy and CDK4/6 Inhibitors

2026 · Sreeja Sreekumar, Migdalia E. Gonzalez, et al. · Molecular Cancer Therapeutics

Abstract 329: PLK1 inhibitor onvansertib potentiates the antitumor efficacy of trastuzumab deruxtecan (T-DXd) and reverses its resistance in therapy-resistant HER2-low breast cancer models.

2026 · Sreeja Sreekumar, Elodie Montaudon, et al. · Cancer Research

Works count: 3

Citation count: 6

H-index: 1

I10-index: